Skip navigation
9

Össur Academy Hosts Hip Osteoarthritis Symposium

Dr. Faucett

Dr. Faucett of the Orthopaedic Center in Washington, D.C. lectures on diagnosing hip pain.

Following the success of last year’s Knee Osteoarthritis (OA) Symposium, Össur Academy welcomed 20 hand-selected physicians to “Hip Osteoarthritis: Defining Standards of Clinical Management” in Dana Point, CA on Feb. 23-24. Össur’s own Dr. Axel Schulz, Medical Director EMEA and Symposium Chair, and Marje Albohm, Clinical Research and Fellowship Director and Symposium Program Director, brought together key physician opinion leaders to collaborate on newly-developed clinical protocols, demonstrating Össur’s commitment to partnering with medical professionals in order to improve patient outcomes.

During the two-day symposium, participants engaged in an informative and highly interactive discussion with the multi-disciplinary faculty panel, featuring 7 internationally-recognized physician experts. Through lectures and small workgroups, participants developed expert consensus protocols for treating hip osteoarthritis among 3 different patient populations–the young hip OA patient, the active demanding hip OA patient and the older hip OA patient. These recommendations will be incorporated into a white paper and submitted for publication as well as disseminated to physicians internationally.

Olafur Gylfason

Olafur Gylfason, Össur EVP of Sales and Marketing, kicks off the event.

Eighty percent of those affected by hip OA experience mobility and activity limitations. Given the increased prevalence, total hip replacement (THR) surgery is expected to grow 200% by 2030 in the US alone. This will have significant economic impact; in 2011, the total expenditure for hip replacements was $21 billion. These statistics don’t account for the increased burden on patients and caregivers, nor decreased productivity during recovery from THR surgeries.

While there is no cure for hip OA, it is important for physicians to manage symptoms, decrease pain to improve function and mobility, and slow disease progression. Physicians can achieve these outcomes by exploring non-invasive, non-surgical treatment options first, like Össur’s Unloader Hip, specially designed to reduce pain by optimizing load dispersion and proprioceptive control. Learn more about Unloader Hip here ossur.com/unloader-hip.

The protocol consensus white paper will be released in May. To receive a notification when the white paper is available, please sign up here.